CorMedix Inc (NASDAQ: CRMD) is 169.15% higher on its value in year-to-date trading and has touched a low of $2.57 and a high of $10.15 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CRMD stock was last observed hovering at around $9.73 in the last trading session, with the day’s gains setting it 0.39%.
Currently trading at $10.12, the stock is 22.66% and 56.49% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.93 million and changing 4.01% at the moment leaves the stock 108.32% off its SMA200. CRMD registered 195.04% gain for a year compared to 6-month gain of 73.29%. The firm has a 50-day simple moving average (SMA 50) of $6.4672 and a 200-day simple moving average (SMA200) of $4.8581.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 47.52% loss in the last 1 month and extending the period to 3 months gives it a 106.53%, and is 13.71% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.27% over the week and 5.90% over the month.
CorMedix Inc (CRMD) has around 82 employees, a market worth around $584.53M and $0.81M in sales. Fwd P/E is 253.00. Profit margin for the company is -6589.10%. Distance from 52-week low is 293.77% and -0.30% from its 52-week high. The company has generated returns on investments over the last 12 months (-113.94%).
with sales reaching $10.84M over the same period.The EPS is expected to grow by 31.43% this year.
CorMedix Inc (CRMD) Top Institutional Holders
128.0 institutions hold shares in CorMedix Inc (CRMD), with institutional investors hold 30.20% of the company’s shares. The shares outstanding are 57.76M, and float is at 56.86M with Short Float at 16.30%. Institutions hold 29.90% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 3.55 million shares valued at $15.39 million. The investor’s holdings represent 6.1796% of the CRMD Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 2.9 million shares valued at $12.57 million to account for 5.0476 of the shares outstanding. The other top investors are ELLIOTT INVESTMENT MANAGEMENT L.P. which holds 1.55 million shares representing 2.6964% and valued at over $6.71 million, while NOMURA HOLDINGS INC holds 2.4733 of the shares totaling 1.42 million with a market value of $6.16 million.
CorMedix Inc (CRMD) Insider Activity
The most recent transaction is an insider purchase by Todisco Joseph, the company’s Chief Executive Officer. SEC filings show that Todisco Joseph bought 13,561 shares of the company’s common stock on Mar 13 ’24 at a price of $3.74 per share for a total of $50718.0. Following the purchase, the insider now owns 0.35 million shares.
CorMedix Inc disclosed in a document filed with the SEC on Dec 14 ’23 that DUNTON ALAN W (Director) bought a total of 3,000 shares of the company’s common stock. The trade occurred on Dec 14 ’23 and was made at $3.45 per share for $10350.0. Following the transaction, the insider now directly holds 12250.0 shares of the CRMD stock.
Still, SEC filings show that on Dec 15 ’23, DUNTON ALAN W (Director) acquired 3,000 shares at an average price of $3.30 for $9900.0. The insider now directly holds 15,250 shares of CorMedix Inc (CRMD).
